The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
What Changes In Market Value Are Expected For The Messenger Ribonucleic Acid (MRNA) Manufacturing Service Market Over The 2026–2030 Period?
Recent years have witnessed a rapid expansion in the messenger ribonucleic acid (mrna) manufacturing service market size. This market is projected to expand from $6.14 billion in 2025 to $7.12 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 15.9%. Several factors contributed to this historical growth, including the surge in mrna therapeutics research, the necessity for emergency vaccine manufacturing, restricted in-house mrna production capabilities, an increase in CDMO collaborations, and the enlargement of biotech product portfolios.
The messenger ribonucleic acid (mrna) manufacturing service market is anticipated to experience significant expansion over the coming years. Its valuation is projected to reach $12.97 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 16.2%. This projected growth throughout the forecast period stems from factors such as a rise in mRNA therapy trials, an increase in contract manufacturing demand, the advancement of personalized medicine, greater outsourcing activities by biotechnology companies, and the scaling up of commercial mRNA products. Key trends anticipated during this period encompass integrated mRNA process development services, large-scale in vitro transcription production, comprehensive LNP encapsulation services, accelerated technology transfer initiatives, and GMP-grade mRNA batch manufacturing.
Access Your Free Sample Report For In-Depth Market Analysis:
https://www.thebusinessresearchcompany.com/sample.aspx?id=33216&type=smp
Which Major Drivers Are Influencing The Expansion Of The Messenger Ribonucleic Acid (MRNA) Manufacturing Service Market?
The increasing clinical trial activity is anticipated to drive the expansion of the messenger ribonucleic acid (mRNA) manufacturing service market in the future. Clinical trial activity pertains to all operations involved in carrying out and overseeing clinical studies to evaluate medical interventions in humans. This activity is on the rise primarily due to the growing adoption of digital and decentralized trial models, which enable more rapid patient recruitment, remote supervision, and more streamlined data collection across diverse populations. Messenger ribonucleic acid (mRNA) manufacturing services bolster clinical trial activity by guaranteeing swift and adaptable production of mRNA-based therapies, thus ensuring timely delivery for various trial stages and accelerating overall drug development. For instance, in December 2024, data from the Association of the British Pharmaceutical Industry (ABPI), a UK-based trade association, indicated that the number of industry clinical trials launched in the UK climbed to 426 in 2023, from 411 in 2022. Consequently, the surge in clinical trial activity is fueling the growth of the messenger ribonucleic acid (mRNA) manufacturing service market.
How Is The Messenger Ribonucleic Acid (MRNA) Manufacturing Service Market Broken Down By Segment Categories?
The messenger ribonucleic acid (mrna) manufacturing service market covered in this report is segmented –
1) By Service Type: Process Development; Analytical Testing; Manufacturing; Fill-Finish; Other Service Types
2) By Scale of Operation: Research And Preclinical Scale; Clinical Scale; Commercial Scale
3) By Application: Vaccines; Therapeutics; Research; Other Applications
4) By End-User: Pharmaceutical And Biotechnology Companies; Academic And Research Institutes; Other End-Users
Subsegments:
1) By Process Development: Template Design And Optimization; In Vitro Transcription Process Design; Formulation Development; Process Scale-Up And Technology Transfer; Process Validation Support
2) By Analytical Testing: Identity And Purity Testing; Potency And Functional Assays; Impurity And Contaminant Analysis; Stability And Shelf Life Studies; Quality Control Release Testing
3) By Manufacturing: Plasmid Deoxyribonucleic Acid Production; In Vitro Transcription Manufacturing; Enzymatic Capping And Tailoring; Purification And Concentration; Large-Scale Batch Production
4) By Fill-Finish: Aseptic Filling Services; Vial And Syringe Filling; Lyophilization Services; Labeling And Packaging; Cold Chain Handling And Storage
5) By Other Service Types: Regulatory Support Services; Quality Assurance And Documentation; Supply Chain And Logistics Support; Technology Consulting Services; Custom Manufacturing Solutions
Which Trends Are Shaping The Messenger Ribonucleic Acid (MRNA) Manufacturing Service Market?
Leading firms within the messenger ribonucleic acid (mRNA) manufacturing service market are prioritizing the creation of advanced techniques, such as in vitro transcription (IVT), to speed up the output of top-tier, therapeutic-grade mRNA for vaccines and personalized therapies. In vitro transcription (IVT) is a lab-based method wherein mRNA is synthesized from a DNA blueprint using RNA polymerase enzymes, allowing for mRNA creation external to biological cells for purposes spanning research, therapy, or vaccination. A pertinent example is that in May 2025, GenScript Biotech Corporation, a China-based biotechnology company, introduced a manufacturing service for mRNA adhering to GMP-like standards, designed to facilitate early-stage clinical investigations and research supporting investigational new drug applications. This offering delivers highly pure and scalable in vitro transcription (IVT) processes, ensuring strict oversight of key quality metrics like capping efficiency, poly(A) tail length, and impurity profiles. It aids in a swift progression from initial research phases to clinical trials through facilitating uniform production across batches, adaptable tailoring for various mRNA designs, and shortened development periods. Furthermore, the GMP-comparable structure guarantees preparedness for regulatory scrutiny by means of improved tracking, uniform operational procedures, and thorough quality records, assisting developers in mitigating risks associated with advanced manufacturing stages and expediting advancement in clinical trials.
Which Players Are Present In The Messenger Ribonucleic Acid (MRNA) Manufacturing Service Market Space?
Major companies operating in the messenger ribonucleic acid (mrna) manufacturing service market are Thermo Fisher Scientific Inc., Merck KGaA, FUJIFILM Biotechnologies, Evonik Industries AG, Lonza Group AG, Charles River Laboratories International Inc., Samsung Biologics Co. Ltd., WuXi Biologics Inc., Recipharm AB, Curia Global Inc., Emergent BioSolutions Inc., AGC Biologics Inc., Corden Pharma International GmbH, Rentschler Biopharma SE, GenScript ProBio, ST Pharm Co. Ltd., etherna Immunotherapies NV, BIOMAY AG., Porton Advanced Solutions Ltd., Wacker Biotech GmbH.
Get The Full Messenger Ribonucleic Acid (MRNA) Manufacturing Service Market Report:
Where Is The Messenger Ribonucleic Acid (MRNA) Manufacturing Service Market Most Concentrated Geographically?
North America was the largest region in the mRNA manufacturing service market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the messenger ribonucleic acid (mrna) manufacturing service market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Messenger Ribonucleic Acid (MRNA) Manufacturing Service Market Report For Competitive Insights:
https://www.thebusinessresearchcompany.com/customise?id=33216&type=smp
Browse Through More Reports Similar to the Global Messenger Ribonucleic Acid (MRNA) Manufacturing Service Market 2026, By The Business Research Company
Messenger Ribonucleic Acid Mrna Synthesis Raw Materials Market Report 2026
Ribonucleic Acid Rna Sequencing Market Report 2026
Nucleic Acid Therapeutics Market Report 2026
https://www.thebusinessresearchcompany.com/report/nucleic-acid-therapeutics-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model